Bristol-Myers Squibb Co. (BMY) Tops Q1 EPS by 1c; Sales Light
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $63.70 --0%
Financial Fact:
Net Earnings Attributable to Noncontrolling Interest: 13M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Net Earnings Attributable to Noncontrolling Interest: 13M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Bristol-Myers Squibb Co. (NYSE: BMY) reported Q1 EPS of $0.64, $0.01 better than the analyst estimate of $0.63. Revenue for the quarter came in at $5.25 billion versus the consensus estimate of $5.26 billion.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Zenas BioPharma, Inc. (ZBIO) Reports Q2 Loss of $1.77
- BK Technologies (BKTI) Tops Q2 EPS by 11c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
